Literature DB >> 19352567

Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study.

H H Tan1, G H Lee, K T J Thia, H S Ng, W C Chow, H F Lui.   

Abstract

INTRODUCTION: Minimal hepatic encephalopathy (mHE) has been reported in up to 84 percent of cirrhotics. The natural history of mHE has not been well-described. We designed a three-year prospective cohort study to determine the prevalence and natural history of mHE among cirrhotic patients.
METHODS: The patient cohort comprising 62 consecutive outpatients with cirrhosis were assessed at baseline and followed-up with a repeat assessment three years later. The assessments include: (1) Neuropsychometric analysis (digit-symbol substitution test, block-design test, number-connection test A); (2) Clinical, biochemical assessment; and (3) Quality of life (QOL) assessment (abbreviated sickness impact profile).
RESULTS: Baseline characteristics were: age 52.9 +/- 11.0 years; Child's A:B:C was 46:14:2. mHE was detected in 33.9 percent of the cohort. Older age, a higher Child-Pugh score and female gender were independently associated with mHE. mHE was associated with a poorer QOL. Follow-up assessment three years later showed that seven patients had died, while six were lost to follow-up; these patients had significantly higher baseline Child's scores. Of the remaining patients, 36/49 (73 percent) agreed to a repeat evaluation. In this group, none had mHE. QOL remained impaired despite the resolution of mHE.
CONCLUSION: It has been shown for the first time that mHE can revert to a normal state in a significant proportion of patients with well-compensated cirrhosis.

Entities:  

Mesh:

Year:  2009        PMID: 19352567

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  10 in total

Review 1.  Advances in the evaluation and management of minimal hepatic encephalopathy.

Authors:  Jennifer Y Montgomery; Jasmohan S Bajaj
Journal:  Curr Gastroenterol Rep       Date:  2011-02

2.  Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy.

Authors:  Saidan Ding; Leping Liu; Huajun Jing; Jieya Xie; Xiaobin Wang; Jinpeng Mao; Bicheng Chen; Qichuan Zhuge
Journal:  Hepatol Int       Date:  2013-03-13       Impact factor: 6.047

3.  Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China.

Authors:  Su-Wen Li; Kai Wang; Yong-Qiang Yu; Hai-Bao Wang; Yuan-Hai Li; Jian-Ming Xu
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

4.  A current review of the diagnostic and treatment strategies of hepatic encephalopathy.

Authors:  Z Poh; P E J Chang
Journal:  Int J Hepatol       Date:  2012-10-21

5.  Limonene in exhaled breath is elevated in hepatic encephalopathy.

Authors:  M E O'Hara; R Fernández Del Río; A Holt; P Pemberton; T Shah; T Whitehouse; C A Mayhew
Journal:  J Breath Res       Date:  2016-11-21       Impact factor: 3.262

6.  Dopamine Burden Induced the Inactivation of Sonic Hedgehog Signaling to Cognitive Decline in Minimal Hepatic Encephalopathy.

Authors:  Saidan Ding; Jianjing Yang; Xueli Huang; Leping Liu; Jiangnan Hu; Zhu Xu; Qichuan Zhuge
Journal:  Aging Dis       Date:  2017-07-21       Impact factor: 6.745

7.  Modulation of neural activation following treatment of hepatic encephalopathy.

Authors:  Mark J W McPhail; Robert Leech; Vijay P B Grover; Julie A Fitzpatrick; Novraj S Dhanjal; Mary M E Crossey; Henning Pflugrad; Brian K Saxby; Keith Wesnes; M Alex Dresner; Adam D Waldman; Howard C Thomas; Simon D Taylor-Robinson
Journal:  Neurology       Date:  2013-02-20       Impact factor: 9.910

8.  Predictors of health-related quality of life in outpatients with cirrhosis: results from a prospective cohort.

Authors:  Maja Thiele; Gro Askgaard; Hans B Timm; Ole Hamberg; Lise L Gluud
Journal:  Hepat Res Treat       Date:  2013-12-22

9.  Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom.

Authors:  Julian F Guest; Kam Nanuwa; Rob Barden
Journal:  Health Qual Life Outcomes       Date:  2014-06-10       Impact factor: 3.186

10.  Elevated intracranial dopamine impairs the glutamate‑nitric oxide‑cyclic guanosine monophosphate pathway in cortical astrocytes in rats with minimal hepatic encephalopathy.

Authors:  Saidan Ding; Weilong Huang; Yiru Ye; Jianjing Yang; Jiangnan Hu; Xiaobin Wang; Leping Liu; Qin Lu; Yuanshao Lin
Journal:  Mol Med Rep       Date:  2014-07-16       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.